Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Cardiac Diagnostics and Monitoring
Reveal LINQ™ insertable cardiac monitor (ICM) is superior to site-specific usual care for atrial fibrillation (AF) detection in large- and small-vessel stroke patients.1
Reveal LINQ™ ICM
To determine whether long-term cardiac monitoring is superior to usual care for AF detection in patients with stroke attributed to large- or small-vessel disease through 12 months of follow-up.
Compare incidence rates of AF between study arms through 36 months of follow-up.
12.1% (n = 27) in the Reveal LINQ ICM arm versus 1.8% (n = 4) in the control group.
Detection of AF at 12 months
Hazard ratio, 8.8 (95% CI, 3.5–22.2)
p < 0.001 by log-rank test
Bernstein RA, Kamel H, Granger CB, et al. Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial. JAMA. June 1, 2021;325(21):2169–2177.